They suggested that in RA patients, 6-phosphofuran-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3), an essential rate-limiting enzyme of the glycolytic pathway is inhibited. The gene discussed is PFKFB3; the disease is rheumatoid arthritis.